Next Article in Journal
Chemotherapy Response Score in Ovarian Cancer Patients: An Overview of Its Clinical Utility
Previous Article in Journal
Role of Endoscopic Ultrasound-Guided Fine Needle Aspiration (EUS-FNA) in the Diagnosis of Suspicious Malignant Esophageal Strictures
Previous Article in Special Issue
Machine Learning Based on Computed Tomography Pulmonary Angiography in Evaluating Pulmonary Artery Pressure in Patients with Pulmonary Hypertension
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

A Novel CT Perfusion-Based Fractional Flow Reserve Algorithm for Detecting Coronary Artery Disease

1
Department of Radiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China
2
Discipline of Medical Radiation Science, Curtin Medical School, Curtin University, Perth 6845, Australia
3
School of Biomedical Engineering, Sun Yat-sen University, Shenzhen 518107, China
4
Department of Cardiology, The Sixth Medical Center, Chinese PLA General Hospital, Beijing 100048, China
*
Authors to whom correspondence should be addressed.
J. Clin. Med. 2023, 12(6), 2154; https://doi.org/10.3390/jcm12062154
Submission received: 4 January 2023 / Revised: 23 February 2023 / Accepted: 28 February 2023 / Published: 9 March 2023
(This article belongs to the Special Issue Recent Advances in Cardiovascular Imaging 2.0 Edition)

Abstract

:
Background: The diagnostic accuracy of fractional flow reserve (FFR) derived from coronary computed tomography angiography (CCTA) (FFR-CT) needs to be further improved despite promising results available in the literature. While an innovative myocardial computed tomographic perfusion (CTP)-derived fractional flow reserve (CTP-FFR) model has been initially established, the feasibility of CTP-FFR to detect coronary artery ischemia in patients with suspected coronary artery disease (CAD) has not been proven. Methods: This retrospective study included 93 patients (a total of 103 vessels) who received CCTA and CTP for suspected CAD. Invasive coronary angiography (ICA) was performed within 2 weeks after CCTA and CTP. CTP-FFR, CCTA (stenosis ≥ 50% and ≥70%), ICA, FFR-CT and CTP were assessed by independent laboratory experts. The diagnostic ability of the CTP-FFR grouped by quantitative coronary angiography (QCA) in mild (30–49%), moderate (50–69%) and severe stenosis (≥70%) was calculated. The effect of calcification of lesions, grouped by FFR on CTP-FFR measurements, was also assessed. Results: On the basis of per-vessel level, the AUCs for CTP-FFR, CTP, FFR-CT and CCTA were 0.953, 0.876, 0.873 and 0.830, respectively (all p < 0.001). The sensitivity, specificity, accuracy, positive predictive value (PPV) and negative predictive value (NPV) of CTP-FFR for per-vessel level were 0.87, 0.88, 0.87, 0.85 and 0.89 respectively, compared with 0.87, 0.54, 0.69, 0.61, 0.83 and 0.75, 0.73, 0.74, 0.70, 0.77 for CCTA ≥ 50% and ≥70% stenosis, respectively. On the basis of per-vessel analysis, CTP-FFR had higher specificity, accuracy and AUC compared with CCTA and also higher AUC compared with FFR-CT or CTP (all p < 0.05). The sensitivity and accuracy of CTP-FFR + CTP + FFR-CT were also improved over FFR-CT alone (both p < 0.05). It also had improved specificity compared with FFR-CT or CTP alone (p < 0.01). A strong correlation between CTP-FFR and invasive FFR values was found on per-vessel analysis (Pearson’s correlation coefficient 0.89). The specificity of CTP-FFR was higher in the severe calcification group than in the low calcification group (p < 0.001). Conclusions: A novel CTP-FFR model has promising value to detect myocardial ischemia in CAD, particularly in mild-to-moderate stenotic lesions.

1. Introduction

Coronary computed tomography angiography (CCTA) can provide excellent anatomical information on coronary arteries and has a high negative predictive value for detecting obstructive coronary artery disease (CAD) [1,2,3]. Although CCTA is widely used for clinical assessment of CAD, it does not provide functional assessment of coronary arteries [4,5]. Fractional flow reserve (FFR) derived from coronary computed tomography angiography (FFR-CT) is becoming a gatekeeper for assessing hemodynamics of coronary arteries and the guide for revascularization, with better agreement with fractional flow reserve (FFR) [6,7,8].
Traditional FFR-CT based on computational fluid dynamics (CFD) and deep learning relies on a population-averaged physiological hypothesis model to estimate exit resistance to simulate boundary conditions. However, due to individual differences between patients, this quantification and distribution of total coronary blood flow can affect coronary exit resistance and therefore the accuracy of FFR-CT [9,10]. Thus, FFR-CT needs to be further improved regarding the diagnostic accuracy and the identification of the gray zone (FFR between 0.75 and 0.80) [11].
Previous studies have demonstrated that the equivalent circuit model of coronary circulation is mainly influenced by the outlet resistance and that the effect of different values for the inlet pressure on the FFR can be entirely ignored [12,13]. A study has developed a digital arterial model by improving the outlet resistance of the artery, providing important information on the magnitude of the hemodynamic parameters experienced in localized sites. This provides hope for future studies addressing medical implant design [14]. In addition, parameters such as outlet resistance can predict the formation and progression of plaque [15]. It has also been shown that the accuracy of hemodynamics in the abdominal aorta and visceral arteries can be improved by adjusting relevant parameters such as outlet resistance [16]. Therefore, focusing on outlet resistance to improve boundary conditions may lead to the discovery of more experimental work on the cardiovascular system, and even treatment or prognosis in the future.
Dynamic stress myocardial computed tomography perfusion (CTP) has been shown to be accurate for quantitative and semi-quantitative assessment of myocardial ischemia in single and multicenter studies [17,18,19]. CTP was progressively optimized to reduce radiation doses, and the CTP-myocardial blood flow (MBF) was comparable to FFR-CT in identifying the lesions causing ischemia [20]. Currently, myocardial CTP-based FFR (CTP-FFR) models have been proposed [21]. CTP is performed during pharmacological congestion, which is the same physiological state as when invasive FFR is measured. Thus, MBF within the myocardial perfusion territory can directly quantify the total coronary blood flow better simulating the boundary conditions of FFR-CT. This approach has been validated in our previous study showing the repeatability and accuracy of using CTP-FFR in assessing coronary stenosis [21].
Thus, we developed a new algorithm based on the CTP to measure FFR through outlining myocardial perfusion regions and improving boundary conditions. The aim of this study was to investigate the feasibility and diagnostic performance of this new CTP-FFR in detecting ischemia while using invasive FFR as the reference standard.

2. Materials and Methods

2.1. Study Design and Patients

The study was designed to use the CTP-based outlet boundary condition (BC) model to calculate CTP-FFR in patients with suspected CAD.
This research was approved by the local clinical institutional ethics committee. All the patients provided written informed consent. A total of 93 patients (37 patients from Beijing Anzhen Hospital, Capital Medical University, and 56 patients from the First Medical Centre of the General Hospital of the Chinese People’s Liberation Army) with suspected CAD were finally enrolled in this retrospective study from March 2019 to September 2020. Among all the participants, stress CTP and CCTA were performed first, followed by invasive coronary angiography (ICA), quantitative coronary angiography (QCA) and invasive FFR measurements, which were performed within two weeks. Patients with a QCA ranging from 30 to 90% luminal narrowing were included in this study. The study flow chart is shown in Figure 1. Exclusion criteria were as follows: (1) contraindications to the adenosine triphosphate (ATP) stress tests and iodinated contrast agents; (2) women who were pregnant; (3) patients decompensating heart failure and severe liver and renal insufficiency (estimated glomerular filtration rate < 60 mL min−1 1.73 m−2); (4) history of revascularization or stent; (5) acute coronary syndrome; and (6) CCTA and CTP images could not be evaluated due to suboptimal image quality.

2.2. CCTA and CTP Acquisition

Patients were asked to refrain from smoking and caffeine for 24 h and fast for 6 h before the scan. The stress CTP and CCTA were performed using two type of CT vendors, 256-row CT scanner (Revolution CT, GE Healthcare, Milwaukee, WI, USA); 128-row dual-source CT (Somatom Definition Flash, Siemens Healthineers, Forchheim, Germany) cardiac CT protocol consisted of: (1) a positioning scan; (2) a CT calcium score scan; (3) a dynamic stress CTP; and (4) a coronary CTA according to the recommendations of the Society of Cardiovascular Computed Tomography (SCCT). Stress CTP scans were performed during an intravenous injection of ATP (160 μg/kg/min for 3 min). Scanning parameters were as follows: z-coverage, 14 cm; matrix size, 512 × 512; voxel size, 0.625 mm; thickness, 1.25 mm; gantry rotation time, 0.28 s; and tube voltage, 80 kV; for tube current, the Smart-mA technique with 200 mA was used. The exposure time of the stress CTP was 30 s. The contrast agent (Ultravist, 370 mg/mL of iopromide; Bayer, Wayne, NJ, USA) was intravenously injected in the right antecubital vein at a flow rate of 4 to 5 mL/s. Data acquisition was triggered using a bolus-tracking technique, and 50 to 60 mL of the contrast agent was injected, followed by 30 to 35 mL of 0.9% saline solution. A single CCTA scan with the same parameters was performed after 20 min of CTP. The scan range covered the entire heart, from the trachea bifurcation up to the diaphragm. Image data were transferred to a workstation (Siemens Syngo. via, Erlangen, Germany) for quantitative analysis of dynamic CTP including MBF, time attenuation curve (TAC) and left ventricular mass (LVMASS). From the MBF map, we selected the one that best represented the area of myocardium associated with the target vessel. Within this cross-section, an area of interest with a minimum area of 50 mm2 was outlined to sample the MBF within the suspected perfusion defect [22]. The total coronary artery calcium score (CACS) was measured.
The effective radiation dose was calculated by multiplying the dose–length product by a constant coefficient (k = 0.014 mSvmGy−1cm−1) [23].

2.3. The FFR Based on CTP

The CTP-FFR model and algorithm has recently been developed [21]. Evaluation of CTP-FFR was divided into the following steps (a detailed flow chart is shown in Figure 2). First, CCTA images were segmented by a semi-automatic segmentation algorithm for coronary artery 3D reconstruction and truncation. Next, for CFD simulation and FFR-CT computation, we used the open-source software Open FOAM for numerical simulations of fluid dynamics. The numerical simulation was governed by the following momentum and mass conservation equations for an incompressible fluid.
Finally, with regards to the inlet and outlet boundary conditions, the inlet boundary condition employed the mean aortic pressure (MAP), which can be calculated according to the brachial cuff-based pressure, as MAP = 0.4 × (SBP − DBP) + DBP, where SBP and DBP are brachial systolic and diastolic blood pressures, respectively. With regards to the outlet boundary conditions, a previous study has shown that the MBF calculated by the volume perfusion CT software is greatly underestimated compared with the stress MBF quantified by the gold standard positron emission tomography (PET) [24]. Ishida et al. proposed to calculate the hematocrit–myocardial transfer constant K1 to replace the MBF of volume perfusion CT [25]. In addition, Kikuchi et al. [26] employed a method to correct K1 to MBF. The Renkin–Crone formula is expressed between K1 and MBF, as
K 1 = 1 0.904 exp 1.203 / M B F M B F
In this study, MBF was corrected by using this formula. We used the Voronoi algorithm to distribute myocardial perfusion [27], which has been demonstrated to assess stenosis-specific myocardial perfusion territories accurately. Therefore, the coronary blood flow at the i-th outlet ( Q o u t , i h y p ) is calculated as
Q o u t , i h y p = n = 1 N V o l n × M B F n
where V o l n is the single voxel volume in myocardial perfusion territory, N is the number of all voxels in the myocardial perfusion territory, and M B F n is the MBF in a single voxel. The resistance of the coronary branch at the i-th outlet ( R i h y p ) is expressed as
R i h y p = M A P P v Q o u t , i h y p
where M A P is the mean aortic pressure, and P v is the venous pressure in the venous vessels and is set to 5 mmHg.
Figure 2. The process of FFR non-invasive calculation based on CTP. (a) Acquisition of coronary CTA; (b) 3D reconstruction of coronary artery; (c) meshing of 3D models of coronary artery; (d) determination of myocardial perfusion territory; (e) computation of outlet resistance; (f) Navier–Stokes equations that govern the fluid dynamics of blood; (g) post-processing of patient-specific FFR-CT. Adapted from Xue et al. [21].
Figure 2. The process of FFR non-invasive calculation based on CTP. (a) Acquisition of coronary CTA; (b) 3D reconstruction of coronary artery; (c) meshing of 3D models of coronary artery; (d) determination of myocardial perfusion territory; (e) computation of outlet resistance; (f) Navier–Stokes equations that govern the fluid dynamics of blood; (g) post-processing of patient-specific FFR-CT. Adapted from Xue et al. [21].
Jcm 12 02154 g002

2.4. The Interpretation of CCTA, CTP, FFR-CT

In all patients, an observer (X.X) who had five years’ experience in interpreting cardiovascular disease was blinded to invasive FFR and clinical data, and marked and calculated the stress CTP and CCTA. FFR-CT measurements were performed by an independent core laboratory at Keya Medical in a manner that was blinded to the clinical findings [28].

2.5. Invasive Coronary Angiography and FFR

Conventional multi-position selective angiography via radial artery or femoral artery was performed by cardiovascular imaging machine (GE Innova3100, The Netherlands). QCA and invasive FFR measurements were performed on the vascular branches with stenosis in angiography. Then, ATP (140–180 μg/kg/min) was injected into the peripheral vein to induce the coronary artery to reach the maximum congestion state, and the FFR value was read by the pressure guide wire of a FFR measuring system (ST. Jude Medical Co., Ltd., Shanghai, China). The pressure wire was positioned in a vessel segment (≥1.5 mm in diameter) that was 20 mm distal to a stenosis. QCA and FFR were analyzed at the clinical site by a cardiologist with five years of experience who was blinded to stress CTP and CCTA findings.

2.6. Statistical Analysis

Statistical analysis was performed with SPSS version 25.0 (IBM SPSS Statistics, IBM Corporation, Armonk, NY, USA) and MedCalc (v20.1.0). Quantitative variables were expressed as mean ± SD if normally distributed, while those that did not conform to the normal distribution were represented by the median and inter quartile range (IQR). Categorical variables were expressed as frequency and rate. The sensitivity, specificity, accuracy, positive predictive value (PPV) and negative predictive value (NPV), and their corresponding 95% confidence intervals (CIs) were calculated for CTP-FFR, CTP, FFR-CT and the combination of the three for the diagnosis of ischemic lesions. In addition, diagnostic performance of CCTA with stenosis ≥ 50% and ≥ 70% was calculated. The Chi-square test and the McNemar test were used to compare sensitivities, specificities and accuracies to compare diagnostic performance characteristics in subgroups, and the DeLong test was used to compare areas under the curve (AUCs) of receiver-operating characteristics among CTP-FFR, CTP, FFR-CT and CCTA. FFR ≤ 0.8 was used as the boundary value for diagnosis of ischemic lesions. Diagnostic performance of CTP-FFR was also compared between subgroups stratified by coronary artery calcium (CAC) scoring < 400 and ≥ 400 [29], stenosis of QCA (mild, 30–49%; moderate, 50–69%; and severe, ≥70%), vessel nomenclature (left anterior descending coronary artery and left circumflex coronary artery) or lesion location on vessel (proximal, middle and distal). The Pearson correlation coefficient and Bland–Altman analysis were used to analyze the correlation between CTP-FFR with invasive FFR. A p < 0.05 value was considered statistically significant.

3. Results

3.1. Patient Characteristics

Baseline characteristics of the study population are shown in Table 1. A total of 93 patients (71 men and 22 women; 59.2 ± 10.9 years old) were finally enrolled and successfully underwent CCTA and the stress CTP, with 103 vessels undergoing the FFR and QCA examination for the analysis in our study, including LAD 82% (84/103) and LCX 18% (19/103). On a per-vessel basis, medians value of 0.81 (IQR: 0.74 to 0.87) and 0.82 (IQR: 0.71 to 0.86) were found for CTP-FFR and invasive FFR, respectively. The detailed patient baseline characteristics are shown in Table 1.

3.2. CCTA, CTP and ICA Measurements

Among the 103 vessels, proximal, middle and distal stenoses were found on CCTA in 59 (57%), 38 (37%) and 6 (6%) vessels, respectively. All vessels were divided into 79 (77%) with low calcification (CAC < 400) and 24 (23%) with severe calcification (CAC ≥ 400), according to the Agatston scores (Table 1).
QCA showed coronary stenosis of < 50% in 28 vessels (27%), and stenosis of ≥ 50% in 75 vessels (73%), of which 55 vessels (53%) were ≥ 70% stenosis. Eventually, ICA and FFR demonstrated hemodynamically significant stenosis by an invasive FFR ≤ 0.80 in 47 (46%) out of 103 vessels, and 44 (47%) out of 93 patients (Table 1).

3.3. Diagnostic Performance of CCTA, FFR-CT, CTP and CTP-FFR

The AUCs of CCTA for evaluating stenosis of ≥ 50%, CTP and FFR-CT on a per-vessel analysis were 0.830, 0.876 and 0.873, respectively (Figure 3). On a per-vessel analysis for detecting flow-limiting stenosis ≥ 50%, the sensitivity, specificity, accuracy, PPV and NPV for CCTA alone were 0.87, 0.54, 0.69, 0.61 and 0.83, respectively. For ≥ 70% stenosis, the corresponding values on per-vessel analysis were 0.75, 0.73, 0.74, 0.70 and 0.77, respectively (Table 2).
The AUC of CTP-FFR for per vessel was 0.953 (Figure 3), which was significantly higher than CTP, FFR-CT or CCTA interpretation on a per-vessel level (all p < 0.05). The diagnostic performance of CTP-FFR ≤ 0.8 for detecting CAD, compared with invasive FFR, is provided in Table 2. CTP-FFR demonstrated a vessel-based sensitivity, specificity, accuracy, PPV and NPV of 0.87, 0.88, 0.87, 0.85 and 0.89, respectively.
On a per-vessel basis, both for ≥ 50% and ≥ 70% stenosis, higher specificity and accuracy of CTP-FFR over CCTA were demonstrated (all p < 0.05). In addition, the sensitivity and accuracy of CTP-FFR + CTP + FFR-CT were also improved over FFR-CT alone (both p < 0.05). As for specificity, it was also improved compared with FFR-CT or CTP alone (both p < 0.01).
On a per-vessel basis, the CTP-FFR had a strong correlation with invasive FFR (Pearson’s correlation coefficient 0.89, 95%CI: 0.85–0.93, p < 0.001) (Figure 4). Bland–Altman analysis showed that the mean difference in total vessels was 0 (95% limits of agreement –0.106 to 0.106; Figure 4).

3.4. Diagnostic Performance of CTP-FFR in the Subgroups Analysis

CTP-FFR and FFR were in good agreement on a per-vessel basis regardless of calcium score burden: CAC < 400 (mean difference 0.002; 95% limits of agreement: −0.106 to 0.110), CAC ≥ 400 (mean difference −0.007; 95% limits of agreement: −0.105 to 0.090) (Figure 5). The specificity of CTP-FFR was significantly higher in the severe calcification group than in the low calcification group (p < 0.001, Table 3). Figure 6 shows a case of CTP-FFR with CCTA and ICA.
Regardless of the total calcium burden, CTP-FFR showed improved diagnostic sensitivity, specificity for vessels with 30–49% and 50–69% stenosis compared with vessels with stenosis ≥ 70% as defined by QCA (all p < 0.01, Table 3). CTP-FFR demonstrated comparably high diagnostic performance between subgroups. In short, with the exception of QCA, the presence of these lesion characteristics did not significantly impact the diagnostic performance of CTP-FFR.

3.5. Performance of CTP-FFR Grouped by FFR

The diagnostic accuracies of CTP-FFR in determining hemodynamic significance among different groups of FFR ranges were shown in Figure 7. On a per-vessel basis, CTP-FFR correctly identified all 22 vessels with an FFR ≤ 0.70 and all 12 vessels with an FFR > 0.90 by using the standard threshold FFR of 0.80. CTP-FFR correctly identified 19 vessels with an FFR of 0.70 to 0.80, while the other 6 vessels in this group were false negatives. In the subgroup with an FFR of 0.8–0.9, CTP-FFR was correctly judged in 37 out of 44 vessels, 7 of which were false positives. A significant difference was found in the diagnostic accuracy of one group’s (FFR 0.70 to 0.80) lesions versus the other group with FFR ≤ 0.7 (p = 0.014). However, no significant difference was found when comparing the accuracy of determining functional significance in patients with the group FFR 0.70 to 0.80 versus lesions with 0.8 < FFR ≤ 0.9 (p = 0.409) or versus lesions with FFR > 0.9 (p = 0.064).

4. Discussion

We proposed a CTP-based outlet BC model involving the quantification of total hyperemic coronary blood flow and the distribution of outlet coronary blood flow to estimate outlet resistance and FFR-CT, and validated the feasibility of CTP-FFR. Our main findings of this study included: (1) CTP-FFR has a higher diagnostic performance for patients with CAD than CCTA or conventional FFR-CT or CTP, and the combination of CTP-FFR + CTP + FFR-CT has specific incremental diagnostic value. (2) For vessels with mild and moderate stenosis, CTP-FFR has higher diagnostic performance. (3) CTP-FFR is less affected by coronary calcification.
Non-invasive FFR-CT provides coronary hemodynamic information and is considered as a gatekeeper and guides clinical decision-making in patients with CAD [8,30]. Previously, FFR-CT modeled CFD primarily by transluminal attenuation gradients (TAG) and diameter and left ventricular mass (LVM) to estimate pressure [31,32,33], and used patient-specific physiological assumptions to model boundary conditions, which are influenced by exit resistance, the reliability of which in turn depends on the physiology of the coronary blood flow circulation hypothetical model and is limited by it. There is currently no definitive physiological assumption that can accurately quantify patient-specific coronary blood flow and outlet resistance [34,35]. Although artificial intelligence (AI)-based FFR-CT (AI-FFR-CT) is maturing and enables timely on-site processing [36], it is still influenced by image quality, severe calcification and the maximum level of congestion simulated by nitroglycerin. In contrast, dynamic CTP is a non-invasive functional imaging method that quantifies MBF during pharmacological congestion by means of myocardial enhancement patterns following contrast injection as a means of estimating outlet resistance and assigning areas of myocardial perfusion [37], with a diagnostic value similar to MRI and positron emission tomography [38,39]. In addition, the use of techniques such as AI and machine learning (ML), standard low voltage (80 kv), automatic tube current modulation and iterative reconstruction has reduced reconstruction time and improved the quality of low-dose myocardial CTP images [40,41].
Our study showed that the AUC of CTP-FFR was higher than CCTA, MBF or conventional FFR-CT in detecting CAD, and significantly higher than previous AUCs on per-vessel analysis: 0.79–0.92 [6,32,33,42]. CTP-FFR implements an innovative algorithm for FFR-CT, which in combination with MBF and FFR-CT significantly improves the diagnostic performance of non-invasive imaging based on CT. Furthermore, Pearson’s and Bland-Altman analyses also showed strong correlation and agreement between CTP-FFR and FFR. This demonstrated the reliability of CTP-FFR and it was consistent with previous studies that stress CTP has a comparable diagnostic value to FFR-CT, and can further improve diagnostic performance in combination with CCTA and FFR-CT [12,43,44]. Li et al. [45] also found that CTP-MBF was superior to ML-based FFR-CT in detecting lesions with severe stenosis. Our results further validated their findings.
Another important finding of our study was that CTP-FFR showed improved diagnostic sensitivity and specificity for vessels with 30–49% and 50–69% stenosis compared with vessels with stenosis ≥ 70%, as defined by QCA. As for intermediate coronary stenoses (luminal stenosis 30–70%), the accuracy and specificity of FFR-CT was 80–86% and 83–85%, respectively [6,32,42]. Donnelly et al. prospectively investigated a novel in situ FFR-CT algorithm and reported a specificity of 72% for detecting intermediate lesions [46]. In our study, CTP-FFR also had the highest diagnostic value (>80%) in patients with mild and moderate stenosis of the QCA, and this further confirms the improved diagnostic performance of CTP-FFR when compared with CCTA and other approaches.
The diagnostic accuracy was higher in the FFR ≤ 0.7 group than in lesions with an FFR of 0.70 to 0.80 (p = 0.014). This suggests that CTP-FFR may achieve excellent agreement in the presence of severe ischemia. Current studies suggest that, for the diagnostic value of the gray zone, CTP can provide incremental value on top of FFR-CT [22,47]. Due to the limited sample size in this study, further research with inclusion of larger sample sizes is needed to validate the diagnosis of CTP-FFR grouping by FFR, especially in the gray zone in the future.
Finally, we found high concordance for CTP-FFR, even in the presence of severe calcification (CAC ≥ 400). The results showed that CTP-FFR mildly underestimated the severity of local hemodynamics in 103 vessels among the 93 subjects, resulting in 6 false negatives and 7 false positives at 0.7 < FFR ≤ 0.8 and 0.8 < FFR ≤ 0.9, respectively. Eleven of them occurred in the low calcified plaque group with a CAC < 400 and two in the severe calcified plaque group with a CAC ≥ 400. It is suggested that the diagnostic accuracy of CTP-FFR may be less influenced by calcification and more related to the degree of ischemia. Previous studies found in patients with severe calcification, stent placement or coronary artery bypass grafting (CABG) that CTP was superior to FFR-CT in diagnosing ischemia and could guide the outcome after revascularization [48,49]. Our results further confirmed these findings that CTP-FFR is an accurate tool in assessing stenotic coronary lesions, even in the presence of severe calcification.
Based on the non-Newtonian mechanical characteristics of blood and the development of the boundary conditions [50,51], several studies have confirmed that CFD can construct numerical models to obtain the hemodynamic parameters of blood vessels [52,53]. The accuracy of CFD can be significantly improved by sketching and changing the boundary conditions, such as placing multi-layer prism elements [54]. This shows that boundary conditions are currently the focus of optimization for CFD and that improvements in boundary conditions such as CTP-FFR may also be evaluated in the future to guide the development of numerical models and the treatment of targeted drugs that follow the blood circulation [55].
Our study had several limitations. Firstly, this was a retrospective study involving two clinical sites and the results may be somewhat biased due to the small sample size. Subsequently we will also include more subjects and increase the number of gray zones. Secondly, due to the extremely thin myocardium of the right coronary artery, it was challenging to outline the myocardial perfusion zone by an automated algorithm. The MBF of the right ventricle was not calculated. Thirdly, the scans of the stress CTP were performed by GE and Siemens vendors, respectively, and there may have been an effect of machine efficacy on the images; however, we adjusted the parameters and scan sequences to be consistent to minimize the potential impact.

5. Conclusions

Compared with CCTA or traditional FFR-CT or CTP, a newly developed CTP-FFR model offers higher diagnostic value for patients with CAD, especially in mild and moderate stenosis. It also shows the potential value of CTP-FFR in assessing coronary lesions with severe calcification. This offers new options for patients with coronary artery disease and may further enhance clinical diagnosis and improve treatment in the future.

Author Contributions

Conceptualization, X.G. and R.W.; methodology, X.G., R.W. and L.X.; software, X.X.; validation, X.G. and X.X.; formal analysis, X.G. and X.X.; investigation, X.G., H.Z. and K.B.; resources, X.G., L.X. and J.Y.; data curation, X.G., H.Z. and K.B.; writing—original draft preparation, X.G.; writing—review and editing, L.X. and Z.S.; visualization, L.X. and J.Y.; supervision, L.X., J.Y. and Z.S.; project administration, L.X., J.Y. and X.G.; funding acquisition, L.X. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by grants from the National Natural Science Foundation of China (82271986) to Lei Xu, the Capital’s Funds for Health Improvement and Research Foundation of China (2020-1-1052).

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of the Beijing Anzhen Hospital, Capital Medical University (2021164X). All the participants signed informed consent.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data are obtainable on request from the corresponding author in this study. They are not publicly available due to privacy issues.

Acknowledgments

Useful suggestions given by Xiujian Liu and Heye Zhang from School of Biomeical Engineering, Sun Yat-sen University, Shenzhen, China, are also acknowledged. We would like to thank the patients who attended the clinic and participated in our study.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Miller, J.M.; Rochitte, C.E.; Dewey, M.; Arbab-Zadeh, A.; Niinuma, H.; Gottlieb, I.; Paul, N.; Clouse, M.E.; Shapiro, E.P.; Hoe, J.; et al. Diagnostic performance of coronary angiography by 64-row CT. N. Engl. J. Med. 2008, 359, 2324–2336. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Yang, L.; Zhou, T.; Zhang, R.; Xu, L.; Peng, Z.; Ding, J.; Wang, S.; Li, M.; Sun, G. Meta-analysis: Diagnostic accuracy of coronary CT angiography with prospective ECG gating based on step-and-shoot, Flash and volume modes for detection of coronary artery disease. Eur. Radiol. 2014, 24, 2345–2352. [Google Scholar] [CrossRef] [PubMed]
  3. Haase, R.; Schlattmann, P.; Gueret, P.; Andreini, D.; Pontone, G.; Alkadhi, H.; Hausleiter, J.; Garcia, M.J.; Leschka, S.; Meijboom, W.B.; et al. Diagnosis of obstructive coronary artery disease using computed tomography angiography in patients with stable chest pain depending on clinical probability and in clinically important subgroups: Meta-analysis of individual patient data. BMJ Clin. Res. Ed. 2019, 365, l1945. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Toth, G.; Hamilos, M.; Pyxaras, S.; Mangiacapra, F.; Nelis, O.; De Vroey, F.; Di Serafino, L.; Muller, O.; Van Mieghem, C.; Wyffels, E.; et al. Evolving concepts of angiogram: Fractional flow reserve discordances in 4000 coronary stenoses. Eur. Heart J. 2014, 35, 2831–2838. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Douglas, P.S.; Hoffmann, U.; Patel, M.R.; Mark, D.B.; Al-Khalidi, H.R.; Cavanaugh, B.; Cole, J.; Dolor, R.J.; Fordyce, C.B.; Huang, M.; et al. Outcomes of anatomical versus functional testing for coronary artery disease. N. Engl. J. Med. 2015, 372, 1291–1300. [Google Scholar] [CrossRef] [Green Version]
  6. Koo, B.K.; Erglis, A.; Doh, J.H.; Daniels, D.V.; Jegere, S.; Kim, H.S.; Dunning, A.; DeFrance, T.; Lansky, A.; Leipsic, J.; et al. Diagnosis of ischemia-causing coronary stenoses by noninvasive fractional flow reserve computed from coronary computed tomographic angiograms. Results from the prospective multicenter DISCOVER-FLOW (Diagnosis of Ischemia-Causing Stenoses Obtained Via Noninvasive Fractional Flow Reserve) study. J. Am. Coll. Cardiol. 2011, 58, 1989–1997. [Google Scholar] [CrossRef] [Green Version]
  7. Ihdayhid, A.R.; Norgaard, B.L.; Gaur, S.; Leipsic, J.; Nerlekar, N.; Osawa, K.; Miyoshi, T.; Jensen, J.M.; Kimura, T.; Shiomi, H.; et al. Prognostic Value and Risk Continuum of Noninvasive Fractional Flow Reserve Derived from Coronary CT Angiography. Radiology 2019, 292, 343–351. [Google Scholar] [CrossRef] [Green Version]
  8. Fairbairn, T.A.; Nieman, K.; Akasaka, T.; Nørgaard, B.L.; Berman, D.S.; Raff, G.; Hurwitz-Koweek, L.M.; Pontone, G.; Kawasaki, T.; Sand, N.P.; et al. Real-world clinical utility and impact on clinical decision-making of coronary computed tomography angiography-derived fractional flow reserve: Lessons from the ADVANCE Registry. Eur. Heart J. 2018, 39, 3701–3711. [Google Scholar] [CrossRef] [Green Version]
  9. Liu, X.; Xu, C.; Rao, S.; Zhang, Y.; Ghista, D.; Gao, Z.; Yang, G. Physiologically personalized coronary blood flow model to improve the estimation of noninvasive fractional flow reserve. Med. Phys. 2022, 49, 583–597. [Google Scholar] [CrossRef]
  10. Morris, P.D.; van de Vosse, F.N.; Lawford, P.V.; Hose, D.R.; Gunn, J.P. “Virtual” (Computed) Fractional Flow Reserve: Current Challenges and Limitations. JACC. Cardiovasc. Interv. 2015, 8, 1009–1017. [Google Scholar] [CrossRef] [Green Version]
  11. Matsumura-Nakano, Y.; Kawaji, T.; Shiomi, H.; Kawai-Miyake, K.; Kataoka, M.; Koizumi, K.; Matsuda, A.; Kitano, K.; Yoshida, M.; Watanabe, H.; et al. Optimal Cutoff Value of Fractional Flow Reserve Derived From Coronary Computed Tomography Angiography for Predicting Hemodynamically Significant Coronary Artery Disease. Circ. Cardiovasc. Imaging 2019, 12, e008905. [Google Scholar] [CrossRef] [PubMed]
  12. Müller, L.O.; Fossan, F.E.; Bråten, A.T.; Jørgensen, A.; Wiseth, R.; Hellevik, L.R. Impact of baseline coronary flow and its distribution on fractional flow reserve prediction. Int. J. Numer. Methods Biomed. Eng. 2021, 37, e3246. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Fossan, F.E.; Sturdy, J.; Müller, L.O.; Strand, A.; Bråten, A.T.; Jørgensen, A.; Wiseth, R.; Hellevik, L.R. Uncertainty Quantification and Sensitivity Analysis for Computational FFR Estimation in Stable Coronary Artery Disease. Cardiovasc. Eng. Technol. 2018, 9, 597–622. [Google Scholar] [CrossRef] [PubMed]
  14. Hewlin, R.L., Jr.; Kizito, J.P. Development of an Experimental and Digital Cardiovascular Arterial Model for Transient Hemodynamic and Postural Change Studies: “A Preliminary Framework Analysis”. Cardiovasc. Eng. Technol. 2018, 9, 1–31. [Google Scholar] [CrossRef] [PubMed]
  15. Sun, Z.; Xu, L. Computational fluid dynamics in coronary artery disease. Comput. Med. Imaging Graph. 2014, 38, 651–663. [Google Scholar] [CrossRef]
  16. Shi, Y.; Peng, C.; Liu, J.; Lan, H.; Li, C.; Qin, W.; Yuan, T.; Kan, Y.; Wang, S.; Fu, W. A modified method of computed fluid dynamics simulation in abdominal aorta and visceral arteries. Comput. Methods Biomech. Biomed. Eng. 2021, 24, 1718–1729. [Google Scholar] [CrossRef]
  17. Pontone, G.; Baggiano, A.; Andreini, D.; Guaricci, A.I.; Guglielmo, M.; Muscogiuri, G.; Fusini, L.; Fazzari, F.; Mushtaq, S.; Conte, E.; et al. Stress Computed Tomography Perfusion Versus Fractional Flow Reserve CT Derived in Suspected Coronary Artery Disease: The PERFECTION Study. JACC Cardiovasc. Imaging 2019, 12, 1487–1497. [Google Scholar] [CrossRef]
  18. Bamberg, F.; Becker, A.; Schwarz, F.; Marcus, R.P.; Greif, M.; von Ziegler, F.; Blankstein, R.; Hoffmann, U.; Sommer, W.H.; Hoffmann, V.S.; et al. Detection of hemodynamically significant coronary artery stenosis: Incremental diagnostic value of dynamic CT-based myocardial perfusion imaging. Radiology 2011, 260, 689–698. [Google Scholar] [CrossRef] [Green Version]
  19. Kitagawa, K.; Nakamura, S.; Ota, H.; Ogawa, R.; Shizuka, T.; Kubo, T.; Yi, Y.; Ito, T.; Nagasawa, N.; Omori, T.; et al. Diagnostic Performance of Dynamic Myocardial Perfusion Imaging Using Dual-Source Computed Tomography. J. Am. Coll. Cardiol. 2021, 78, 1937–1949. [Google Scholar] [CrossRef]
  20. Yang, D.H.; Kim, Y.H.; Roh, J.H.; Kang, J.W.; Ahn, J.M.; Kweon, J.; Lee, J.B.; Choi, S.H.; Shin, E.S.; Park, D.W.; et al. Diagnostic performance of on-site CT-derived fractional flow reserve versus CT perfusion. Eur. Heart J. Cardiovasc. Imaging 2017, 18, 432–440. [Google Scholar] [CrossRef] [Green Version]
  21. Xue, X.; Liu, X.; Gao, Z.; Wang, R.; Xu, L.; Ghista, D.; Zhang, H. Personalized coronary blood flow model based on CT perfusion to non-invasively calculate fractional flow reserve. Comput. Methods Appl. Mech. Eng. 2023, 404, 115789. [Google Scholar] [CrossRef]
  22. Coenen, A.; Rossi, A.; Lubbers, M.M.; Kurata, A.; Kono, A.K.; Chelu, R.G.; Segreto, S.; Dijkshoorn, M.L.; Wragg, A.; van Geuns, R.M.; et al. Integrating CT Myocardial Perfusion and CT-FFR in the Work-Up of Coronary Artery Disease. JACC Cardiovasc. Imaging 2017, 10, 760–770. [Google Scholar] [CrossRef] [PubMed]
  23. Trattner, S.; Halliburton, S.; Thompson, C.M.; Xu, Y.; Chelliah, A.; Jambawalikar, S.R.; Peng, B.; Peters, M.R.; Jacobs, J.E.; Ghesani, M.; et al. Cardiac-Specific Conversion Factors to Estimate Radiation Effective Dose from Dose-Length Product in Computed Tomography. JACC Cardiovasc. Imaging 2018, 11, 64–74. [Google Scholar] [CrossRef] [PubMed]
  24. Kajander, S.A.; Joutsiniemi, E.; Saraste, M.; Pietilä, M.; Ukkonen, H.; Saraste, A.; Sipilä, H.T.; Teräs, M.; Mäki, M.; Airaksinen, J.; et al. Clinical value of absolute quantification of myocardial perfusion with (15)O-water in coronary artery disease. Circ. Cardiovasc. Imaging 2011, 4, 678–684. [Google Scholar] [CrossRef] [Green Version]
  25. Ishida, M.; Kitagawa, K.; Ichihara, T.; Natsume, T.; Nakayama, R.; Nagasawa, N.; Kubooka, M.; Ito, T.; Uno, M.; Goto, Y.; et al. Underestimation of myocardial blood flow by dynamic perfusion CT: Explanations by two-compartment model analysis and limited temporal sampling of dynamic CT. J. Cardiovasc. Comput. Tomogr. 2016, 10, 207–214. [Google Scholar] [CrossRef]
  26. Kikuchi, Y.; Oyama-Manabe, N.; Naya, M.; Manabe, O.; Tomiyama, Y.; Sasaki, T.; Katoh, C.; Kudo, K.; Tamaki, N.; Shirato, H. Quantification of myocardial blood flow using dynamic 320-row multi-detector CT as compared with 15O-H2O PET. Eur. Radiol. 2014, 24, 1547–1556. [Google Scholar] [CrossRef]
  27. Ide, S.; Sumitsuji, S.; Yamaguchi, O.; Sakata, Y. Cardiac computed tomography-derived myocardial mass at risk using the Voronoi-based segmentation algorithm: A histological validation study. Cardiovasc. Comput. Tomogr. 2017, 11, 179–182. [Google Scholar] [CrossRef]
  28. Liu, X.; Wang, Y.; Zhang, H.; Yin, Y.; Cao, K.; Gao, Z.; Liu, H.; Hau, W.K.; Gao, L.; Chen, Y.; et al. Evaluation of fractional flow reserve in patients with stable angina: Can CT compete with angiography? Eur. Radiol. 2019, 29, 3669–3677. [Google Scholar] [CrossRef]
  29. Montalescot, G.; Sechtem, U.; Achenbach, S.; Andreotti, F.; Arden, C.; Budaj, A.; Bugiardini, R.; Crea, F.; Cuisset, T.; Task Force Members; et al. 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur. Heart J. 2013, 34, 2949–3003. [Google Scholar] [CrossRef]
  30. Nørgaard, B.L.; Gaur, S.; Fairbairn, T.A.; Douglas, P.S.; Jensen, J.M.; Patel, M.R.; Ihdayhid, A.R.; Ko, B.S.H.; Sellers, S.L.; Weir-McCall, J.; et al. Prognostic value of coronary computed tomography angiographic derived fractional flow reserve: A systematic review and meta-analysis. Heart 2022, 108, 194–202. [Google Scholar] [CrossRef]
  31. Taylor, C.A.; Fonte, T.A.; Min, J.K. Computational fluid dynamics applied to cardiac computed tomography for noninvasive quantification of fractional flow reserve: Scientific basis. J. Am. Coll. Cardiol. 2013, 61, 2233–2241. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Nørgaard, B.L.; Leipsic, J.; Gaur, S.; Seneviratne, S.; Ko, B.S.; Ito, H.; Jensen, J.M.; Mauri, L.; De Bruyne, B.; Bezerra, H.; et al. Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: The NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps). J. Am. Coll. Cardiol. 2014, 63, 1145–1155. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Tang, C.X.; Liu, C.Y.; Lu, M.J.; Schoepf, U.J.; Tesche, C.; Bayer, R.R., 2nd; Hudson, H.T., Jr.; Zhang, X.L.; Li, J.H.; Wang, Y.N.; et al. CT FFR for Ischemia-Specific CAD With a New Computational Fluid Dynamics Algorithm: A Chinese Multicenter Study. JACC Cardiovasc. Imaging 2020, 13, 980–990. [Google Scholar] [CrossRef] [PubMed]
  34. Feher, A.; Sinusas, A.J. Quantitative Assessment of Coronary Microvascular Function: Dynamic Single-Photon Emission Computed Tomography, Positron Emission Tomography, Ultrasound, Computed Tomography, and Magnetic Resonance Imaging. Circ. Cardiovasc. Imaging 2017, 10, e006427. [Google Scholar] [CrossRef] [Green Version]
  35. Camici, P.G.; d’Amati, G.; Rimoldi, O. Coronary microvascular dysfunction: Mechanisms and functional assessment. Nat. Rev. Cardiol. 2015, 12, 48–62. [Google Scholar] [CrossRef]
  36. Tesche, C.; De Cecco, C.N.; Baumann, S.; Renker, M.; McLaurin, T.W.; Duguay, T.M.; Bayer, R.R., 2nd; Steinberg, D.H.; Grant, K.L.; Canstein, C.; et al. Coronary CT Angiography-derived Fractional Flow Reserve: Machine Learning Algorithm versus Computational Fluid Dynamics Modeling. Radiology 2018, 288, 64–72. [Google Scholar] [CrossRef] [Green Version]
  37. Van Assen, M.; Pelgrim, G.J.; De Cecco, C.N.; Stijnen, J.M.A.; Zaki, B.M.; Oudkerk, M.; Vliegenthart, R.; Schoepf, U.J. Intermodel disagreement of myocardial blood flow estimation from dynamic CT perfusion imaging. Eur. J. Radiol. 2019, 110, 175–180. [Google Scholar] [CrossRef]
  38. Takx, R.A.; Blomberg, B.A.; El Aidi, H.; Habets, J.; de Jong, P.A.; Nagel, E.; Hoffmann, U.; Leiner, T. Diagnostic accuracy of stress myocardial perfusion imaging compared to invasive coronary angiography with fractional flow reserve meta-analysis. Circ. Cardiovasc. Imaging 2015, 8, e002666. [Google Scholar] [CrossRef] [Green Version]
  39. Tanabe, Y.; Kido, T.; Uetani, T.; Kurata, A.; Kono, T.; Ogimoto, A.; Miyagawa, M.; Soma, T.; Murase, K.; Iwaki, H.; et al. Differentiation of myocardial ischemia and infarction assessed by dynamic computed tomography perfusion imaging and comparison with cardiac magnetic resonance and single-photon emission computed tomography. Eur. Radiol. 2016, 26, 3790–3801. [Google Scholar] [CrossRef]
  40. Wu, D.; Kim, K.; El Fakhri, G.; Li, Q. Iterative Low-Dose CT Reconstruction With Priors Trained by Artificial Neural Network. IEEE Trans. Med. Imaging 2017, 36, 2479–2486. [Google Scholar] [CrossRef]
  41. Tatsugami, F.; Higaki, T.; Nakamura, Y.; Yu, Z.; Zhou, J.; Lu, Y.; Fujioka, C.; Kitagawa, T.; Kihara, Y.; Iida, M.; et al. Deep learning-based image restoration algorithm for coronary CT angiography. Eur. Radiol. 2019, 29, 5322–5329. [Google Scholar] [CrossRef]
  42. Nakazato, R.; Park, H.B.; Berman, D.S.; Gransar, H.; Koo, B.K.; Erglis, A.; Lin, F.Y.; Dunning, A.M.; Budoff, M.J.; Malpeso, J.; et al. Noninvasive fractional flow reserve derived from computed tomography angiography for coronary lesions of intermediate stenosis severity: Results from the DeFACTO study. Circ. Cardiovasc. Imaging 2013, 6, 881–889. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Tanabe, Y.; Kurata, A.; Matsuda, T.; Yoshida, K.; Baruah, D.; Kido, T.; Mochizuki, T.; Rajiah, P. Computed tomographic evaluation of myocardial ischemia. Jpn. J. Radiol. 2020, 38, 411–433. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Van Assen, M.; De Cecco, C.N.; Eid, M.; von Knebel Doeberitz, P.; Scarabello, M.; Lavra, F.; Bauer, M.J.; Mastrodicasa, D.; Duguay, T.M.; Zaki, B.; et al. Prognostic value of CT myocardial perfusion imaging and CT-derived fractional flow reserve for major adverse cardiac events in patients with coronary artery disease. J. Cardiovasc. Comput. Tomogr. 2019, 13, 26–33. [Google Scholar] [CrossRef] [PubMed]
  45. Li, Y.; Yu, M.; Dai, X.; Lu, Z.; Shen, C.; Wang, Y.; Lu, B.; Zhang, J. Detection of Hemodynamically Significant Coronary Stenosis: CT Myocardial Perfusion versus Machine Learning CT Fractional Flow Reserve. Radiology 2019, 293, 305–314. [Google Scholar] [CrossRef]
  46. Donnelly, P.M.; Kolossváry, M.; Karády, J.; Ball, P.A.; Kelly, S.; Fitzsimons, D.; Spence, M.S.; Celeng, C.; Horváth, T.; Szilveszter, B.; et al. Experience With an On-Site Coronary Computed Tomography-Derived Fractional Flow Reserve Algorithm for the Assessment of Intermediate Coronary Stenoses. Am. J. Cardiol. 2018, 121, 9–13. [Google Scholar] [CrossRef]
  47. Nieman, K.; Balla, S. Dynamic CT myocardial perfusion imaging. J. Cardiovasc. Comput. Tomogr. 2020, 14, 303–306. [Google Scholar] [CrossRef]
  48. Shikata, F.; Imagawa, H.; Kawachi, K.; Kido, T.; Kurata, A.; Inoue, Y.; Hosokawa, K.; Nagao, M.; Higashino, H.; Mochizuki, T.; et al. Regional myocardial blood flow measured by stress multidetector computed tomography as a predictor of recovery of left ventricular function after coronary artery bypass grafting. Am. Heart J. 2010, 160, 528–534. [Google Scholar] [CrossRef]
  49. Schoepf, U.J.; van Assen, M. FFR-CT and CT Myocardial Perfusion Imaging: Friends or Foes? JACC Cardiovasc. Imaging 2019, 12, 2472–2474. [Google Scholar] [CrossRef]
  50. Stanley, N.; Timms, W.; Ciero, A.; Hewlin, R.L. Development of 3-D Printed Optically Clear Rigid and Anatomical Vessels for Particle Image Velocimetry Analysis in Cardiovascular Flow. In Proceedings of the ASME International Mechanical Engineering Congress and Exposition, Salt Lake City, UT, USA, 11–14 November 2019. [Google Scholar]
  51. Jhunjhunwala, P.; Padole, P.M.; Thombre, S.B. CFD Analysis of Pulsatile Flow and Non-Newtonian Behavior of Blood in Arteries. Mol. Cell. Biomech. 2015, 12, 37–47. [Google Scholar]
  52. Hewlin, R.L.; Kizito, J.P. Evaluation of the Effect of Simplified and Patient-Specific Arterial Geometry on Hemodynamic Flow in Stenosed Carotid Bifurcation Arteries. In Proceedings of the ASME Early Technical Career Conference, Atlanta, GA, USA, 4–5 November 2011. [Google Scholar]
  53. Karvelas, E.G.; Lampropoulos, N.K.; Karakasidis, T.E.; Sarris, I.E. Blood flow and diameter effect in the navigation process of magnetic nanocarriers inside the carotid artery. Comput. Methods Programs Biomed. 2022, 221, 106916. [Google Scholar] [CrossRef] [PubMed]
  54. Kambayashi, Y.; Takao, H.; Shinohara, K.; Suzuki, T.; Takayama, S.; Fujimura, S.; Masuda, S.; Watanabe, M.; Suzuki, T.; Dahmani, C.; et al. Computational fluid dynamics analysis of tandem carotid artery stenoses: Investigation of neurological complications after carotid artery stenting. Technol. Health Care Off. J. Eur. Soc. Eng. Med. 2016, 24, 673–679. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  55. Karvelas, E.; Liosis, C.; Theodorakakos, A.; Sarris, I.; Karakasidis, T. An Optimized Method for 3D Magnetic Navifation of Nanoparticles inside Human Arteries. Fluids 2021, 6, 97. [Google Scholar] [CrossRef]
Figure 1. Study flow chart. CCTA = coronary computed tomography angiography; CTP-FFR = computed tomography perfusion (CTP)-derived fractional flow reserve (FFR); ICA = invasive coronary angiography; QCA = quantitative coronary angiography; RCA = right coronary artery.
Figure 1. Study flow chart. CCTA = coronary computed tomography angiography; CTP-FFR = computed tomography perfusion (CTP)-derived fractional flow reserve (FFR); ICA = invasive coronary angiography; QCA = quantitative coronary angiography; RCA = right coronary artery.
Jcm 12 02154 g001
Figure 3. Graph showing diagnostic performance of CTP-FFR, CTP, FFR-CT and CCTA. AUC of receiver operating characteristics curve analysis is shown on per vessel for CTP-FFR, CTP, FFR-CT and visual stenosis grading (stenosis ≥ 50%) at CCTA. The dotted line represents the reference line. AUC = area under receiver operating characteristics curve. Other abbreviations same as in Figure 1.
Figure 3. Graph showing diagnostic performance of CTP-FFR, CTP, FFR-CT and CCTA. AUC of receiver operating characteristics curve analysis is shown on per vessel for CTP-FFR, CTP, FFR-CT and visual stenosis grading (stenosis ≥ 50%) at CCTA. The dotted line represents the reference line. AUC = area under receiver operating characteristics curve. Other abbreviations same as in Figure 1.
Jcm 12 02154 g003
Figure 4. (Left) A strong correlation (R = 0.894) is observed between CTP-FFR and FFR. (Right) Bland–Altman analysis of FFR and CTP-FFR on a per-vessel basis. The distribution of red points represents the correlation and consistency of CTP-FFR with FFR. Abbreviations same as in Figure 1.
Figure 4. (Left) A strong correlation (R = 0.894) is observed between CTP-FFR and FFR. (Right) Bland–Altman analysis of FFR and CTP-FFR on a per-vessel basis. The distribution of red points represents the correlation and consistency of CTP-FFR with FFR. Abbreviations same as in Figure 1.
Jcm 12 02154 g004
Figure 5. Bland–Altman analysis of FFR and CTP-FFR on a per-vessel basis in low calcification ((A), CAC < 400) and severe calcification ((B), CAC ≥ 400), respectively. The distribution of red points represents the consistency of CTP-FFR with FFR. CAC = coronary artery calcium. Other abbreviations as in Figure 1.
Figure 5. Bland–Altman analysis of FFR and CTP-FFR on a per-vessel basis in low calcification ((A), CAC < 400) and severe calcification ((B), CAC ≥ 400), respectively. The distribution of red points represents the consistency of CTP-FFR with FFR. CAC = coronary artery calcium. Other abbreviations as in Figure 1.
Jcm 12 02154 g005
Figure 6. Example of a 47-year-old man who presented with atypical chest pain, hypertension and dyslipidemia. (A) CCTA shows stenosis (arrow) is caused by a mixed plaque of the proximal LAD. (B) ICA shows severe stenosis (arrow) with ischemia in LAD (FFR = 0.74). (C) Stress-CTP shows myocardial blood flow (D) CTP-FFR demonstrates value of 0.76 in the LAD. Abbreviations same as in Figure 1 and Table 1.
Figure 6. Example of a 47-year-old man who presented with atypical chest pain, hypertension and dyslipidemia. (A) CCTA shows stenosis (arrow) is caused by a mixed plaque of the proximal LAD. (B) ICA shows severe stenosis (arrow) with ischemia in LAD (FFR = 0.74). (C) Stress-CTP shows myocardial blood flow (D) CTP-FFR demonstrates value of 0.76 in the LAD. Abbreviations same as in Figure 1 and Table 1.
Jcm 12 02154 g006
Figure 7. The diagnostic accuracy of CTP-FFR in correctly identifying the hemodynamically significant lesions among the different invasive FFR groups. All abbreviations same as in Table 1.
Figure 7. The diagnostic accuracy of CTP-FFR in correctly identifying the hemodynamically significant lesions among the different invasive FFR groups. All abbreviations same as in Table 1.
Jcm 12 02154 g007
Table 1. Baseline characteristics of the study population.
Table 1. Baseline characteristics of the study population.
Clinical CharacteristicsN = 93
Age, y59.2 ± 10.9
Male71 (76.3)
BMI, kg/m225.89 ± 2.48
Hyperlipidemia50 (53.8)
Hypertension51 (54.8)
Diabetes24 (25.8)
Current smoker37 (39.8)
Symptoms
  Typical angina64 (68.8)
  Atypical angina29 (31.2)
Medications
  CCB19 (20.4)
  Beta-blocker28 (30.1)
  ACEI/ARB17 (18.3)
  Statins31 (33.3)
  ASA22 (23.7)
  Clopidogrel12 (12.9)
No. of vessels103
  LAD84 (81.6)
  LCX19 (18.4)
Lesion location on vessels
  Proximal59 (57.3)
  Middle38 (36.9)
  Distal6 (5.8)
QCA on per-vessel
 30% ≤ QCA < 50%28 (27.2)
 50% ≤ QCA < 70%20 (19.4)
 ≥70%55 (53.4)
Total Agatston score on per vessel
 <40079 (76.7)
 ≥40024 (23.3)
FFR ≤ 0.80 on per patient44 (47.3)
FFR ≤ 0.80 on per vessel47 (45.6)
Data are presented as mean ± SD or number (%), as appropriate. BMI = body mass index; CCB = calcium-channel blockers; ACEI = angiotensin-converting enzyme inhibitors; ARB = angiotensin receptor blocker; ASA = acetylsalicylic acid; LAD = left anterior descending artery; LCX = left circumflex artery; QCA = quantitative coronary angiography; FFR = fractional flow reserve.
Table 2. Diagnostic performance of CCTA and CTP-FFR on a per-vessel basis.
Table 2. Diagnostic performance of CCTA and CTP-FFR on a per-vessel basis.
CCTA ≥ 50%CCTA ≥ 70%FFR-CTCTPCTP-FFRCTP-FFR + CTP + FFR-CT
Sensitivity87.2 (74.3–95.2)74.5 (59.7–86.1)85.1 (71.7–93.8)87.2 (74.3–95.2)87.2 (74.3–95.2)100.0 (92.5–100.0)
Specificity53.6 (39.7–67.0)73.2 (59.7–84.2)83.9 (71.7–92.4)75.0 (61.6–85.6)87.5 (75.9–94.8)98.2 (90.5–99.9)
Accuracy68.9 (59.1–77.7)73.8 (64.2–82.0)84.5 (76.0–90.9)80.6 (71.6–87.7)87.3 (79.4–93.1)99.0 (94.7–99.9)
PPV61.2 (53.8–68.1)70.0 (59.5–78.8)81.6 (70.7–89.1)74.6 (64.8–82.4)85.4 (74.4–92.2)97.9 (87.1–99.7)
NPV83.3 (69.5–91.7)77.4 (67.2–85.1)87.0 (77.1–93.1)87.5 (76.6–93.8)89.1 (79.4–94.6)100.0 (92.5–100.0)
Values are % (95% CI). PPV = positive predictive value; NPV = negative predictive value. Other abbreviations as in Figure 1.
Table 3. Diagnostic performance of CTP-FFR (≤0.80) with different variables in determining myocardial ischemia with invasive fractional flow reserve as a reference standard (≤0.80) on a per-vessel basis.
Table 3. Diagnostic performance of CTP-FFR (≤0.80) with different variables in determining myocardial ischemia with invasive fractional flow reserve as a reference standard (≤0.80) on a per-vessel basis.
Analysis
Basis
MetricsSensitivitySpecificityAccuracyPPVNPV
No. of vesselsLAD92.7 (80.1–98.5)93.0 (80.9–98.5)92.9 (85.1–97.3)92.7 (80.9–97.4)93.0 (81.7–97.3)
LCX50.0 (11.8–88.2)69.23 (38.6–90.9)63.2 (38.4–83.7)42.9 (19.3–70.2)75.0 (55.5–87.8)
Lesion location on
vessel
Proximal88.9 (70.8–97.7)93.8 (79.2–99.2)91.5 (81.3–97.2)92.3 (75.7–97.9)90.9 (77.4–96.7)
Middle88.2 (63.6–98.5)76.2 (52.8–91.8)81.6 (65.7–92.3)75.0 (57.8–86.8)88.9 (68.0–96.8)
Distal66.7 (9.43–99.2)100.0 (29.2–100.0)83.3 (35.9–99.6)100.0 (19.8–100.0)75.0 (37.7–93.7)
QCA on
per vessel
30% ≤ QCA < 50%100.0 (2.5–100.0)92.6 (75.7–99.1)92.9 (76.5–99.1)33.3 (11.6–65.5)100.0 (83.4–99.9)
50% ≤ QCA < 70%100.0 (29.2–100.0)88.24 (63.6–98.5)90.0 (68.3–98.8)60.0 (29.0–84.7)100.0 (75.9–99.9)
≥70%86.0 (72.1–94.7)75.0 (42.8–94.5)83.6 (71.2–92.2)92.5 (82.1–97.1)60.0 (40.0–77.1)
Total Agatston score on per vessel<40089.2 (74.6–97.0)85.7 (71.5–94.6)87.3 (78.0–93.8)84.6 (72.2–92.1)90.0 (78.0–95.8)
≥40080.0 (44.4–97.5)92.9 (66.1–99.8)87.5 (67.6–97.3)88.9 (54.1–98.2)86.7 (65.1–95.8)
All abbreviations same as in Figure 1, Table 1 and Table 2.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Gao, X.; Wang, R.; Sun, Z.; Zhang, H.; Bo, K.; Xue, X.; Yang, J.; Xu, L. A Novel CT Perfusion-Based Fractional Flow Reserve Algorithm for Detecting Coronary Artery Disease. J. Clin. Med. 2023, 12, 2154. https://doi.org/10.3390/jcm12062154

AMA Style

Gao X, Wang R, Sun Z, Zhang H, Bo K, Xue X, Yang J, Xu L. A Novel CT Perfusion-Based Fractional Flow Reserve Algorithm for Detecting Coronary Artery Disease. Journal of Clinical Medicine. 2023; 12(6):2154. https://doi.org/10.3390/jcm12062154

Chicago/Turabian Style

Gao, Xuelian, Rui Wang, Zhonghua Sun, Hongkai Zhang, Kairui Bo, Xiaofei Xue, Junjie Yang, and Lei Xu. 2023. "A Novel CT Perfusion-Based Fractional Flow Reserve Algorithm for Detecting Coronary Artery Disease" Journal of Clinical Medicine 12, no. 6: 2154. https://doi.org/10.3390/jcm12062154

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop